The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 

Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.

Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease. 

Echocardiography expert Roberto Lang, MD, says artificial intelligence will be so important to cardiac ultrasound in the near future that echo labs not using it will be inefficient and less accurate than labs that do use it.

The American College of Cardiology, Association of Black Cardiologists and several other U.S. societies released a new joint statement on the ruling.

James Kirkpatrick, MD, discussed some of the biggest trends and themes he saw at the American Society of Echocardiography's 2023 annual meeting.

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

And the improved scan times did not come at the expense of image quality but, instead, offered improved signal-to-noise ratio, according to a new study in Skeletal Radiology.

American war veterans take their own lives at a rate much higher than the civilian average. Might AI help formulate some sort of solution? The week of Independence Day seems a fitting time to consider the possibility.